| 【Company Research】Haitong Securities (6837 HK) – FY20 outstanding fee growth offset by weak prop-trading and impairment charges |
| 【Company Research】Venus Medtech (Hangzhou) Inc. (2500 HK) – Comprehensive portfolio in transcatheter solutions for structural heart diseases |
| 【Company Research】Ascentage Pharma Group (6855 HK) – Gear up for commercialization |
| 【Company Research】GSX Techedu (GSX US) – A leading online K12 AST service provider |
| 【Company Research】JS Global Lifestyle (1691 HK) – Market share gains by product innovations |
| 【Company Research】Weichai Power-A (000338 CH) – Growth set to resume after the weak 2020 results |
| 【Company Research】Weichai Power - H (2338 HK) – Growth set to resume after the weak 2020 results |
| 【Company Research】GF Securities (1776 HK) – FY20 brilliant AM weighed on by weak IB and prop-trading |
| 【Company Research】CSC Financial (6066 HK) – FY20 excellent earnings on prop-trading gains |
| 【Company Research】Sinotruk (Hong Kong) (3808 HK) – Market share gain on more proactive strategy |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
